Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030430070> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- W2030430070 endingPage "150" @default.
- W2030430070 startingPage "150" @default.
- W2030430070 abstract "International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004;363:9–17. [OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] Q In patients with acute, uncomplicated Plasmodium falciparum malaria, does the addition of an artemisinin derivative (artesunate) to existing drug treatment reduce treatment failure and transmission potential? Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Infectious disease ★★★★★☆☆ Tropical medicine ★★★★★★☆ ### ![Graphic][5]</img>Data sources: Medline, Cochrane Central Register of Controlled Trials, and investigators in the field. Individual patient data were requested from the original trial datasets. ### ![Graphic][6]</img>Study selection and assessment: randomised controlled trials (RCTs) comparing artesunate plus a standard antimalarial drug with a standard drug alone for acute, uncomplicated P falciparum malaria. Study quality was assessed by adequacy of random allocation, inclusion of … [1]: {openurl}?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DAdjuik%26rft.auinit1%253DM.%26rft.volume%253D363%26rft.issue%253D9402%26rft.spage%253D9%26rft.epage%253D17%26rft.atitle%253DArtesunate%2Bcombinations%2Bfor%2Btreatment%2Bof%2Bmalaria%253A%2Bmeta-analysis.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252803%252915162-8%26rft_id%253Dinfo%253Apmid%252F14723987%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.1016/S0140-6736(03)15162-8&link_type=DOI [3]: /lookup/external-ref?access_num=14723987&link_type=MED&atom=%2Febmed%2F9%2F5%2F150.atom [4]: /lookup/external-ref?access_num=000187711300008&link_type=ISI [5]: /embed/inline-graphic-1.gif [6]: /embed/inline-graphic-2.gif" @default.
- W2030430070 created "2016-06-24" @default.
- W2030430070 creator A5049249235 @default.
- W2030430070 date "2004-09-01" @default.
- W2030430070 modified "2023-09-27" @default.
- W2030430070 title "Review: artesunate added to standard drug treatment reduces treatment failure in malaria" @default.
- W2030430070 doi "https://doi.org/10.1136/ebm.9.5.150" @default.
- W2030430070 hasPublicationYear "2004" @default.
- W2030430070 type Work @default.
- W2030430070 sameAs 2030430070 @default.
- W2030430070 citedByCount "0" @default.
- W2030430070 crossrefType "journal-article" @default.
- W2030430070 hasAuthorship W2030430070A5049249235 @default.
- W2030430070 hasBestOaLocation W20304300701 @default.
- W2030430070 hasConcept C126322002 @default.
- W2030430070 hasConcept C187212893 @default.
- W2030430070 hasConcept C203014093 @default.
- W2030430070 hasConcept C2776120307 @default.
- W2030430070 hasConcept C2778048844 @default.
- W2030430070 hasConcept C2778059366 @default.
- W2030430070 hasConcept C2778371730 @default.
- W2030430070 hasConcept C3020774429 @default.
- W2030430070 hasConcept C71924100 @default.
- W2030430070 hasConcept C95190672 @default.
- W2030430070 hasConceptScore W2030430070C126322002 @default.
- W2030430070 hasConceptScore W2030430070C187212893 @default.
- W2030430070 hasConceptScore W2030430070C203014093 @default.
- W2030430070 hasConceptScore W2030430070C2776120307 @default.
- W2030430070 hasConceptScore W2030430070C2778048844 @default.
- W2030430070 hasConceptScore W2030430070C2778059366 @default.
- W2030430070 hasConceptScore W2030430070C2778371730 @default.
- W2030430070 hasConceptScore W2030430070C3020774429 @default.
- W2030430070 hasConceptScore W2030430070C71924100 @default.
- W2030430070 hasConceptScore W2030430070C95190672 @default.
- W2030430070 hasIssue "5" @default.
- W2030430070 hasLocation W20304300701 @default.
- W2030430070 hasLocation W20304300702 @default.
- W2030430070 hasOpenAccess W2030430070 @default.
- W2030430070 hasPrimaryLocation W20304300701 @default.
- W2030430070 hasRelatedWork W2024299612 @default.
- W2030430070 hasRelatedWork W2081496191 @default.
- W2030430070 hasRelatedWork W2127930530 @default.
- W2030430070 hasRelatedWork W2151292805 @default.
- W2030430070 hasRelatedWork W2353819634 @default.
- W2030430070 hasRelatedWork W2419413447 @default.
- W2030430070 hasRelatedWork W2789348592 @default.
- W2030430070 hasRelatedWork W3147788888 @default.
- W2030430070 hasRelatedWork W3199344978 @default.
- W2030430070 hasRelatedWork W4232389775 @default.
- W2030430070 hasVolume "9" @default.
- W2030430070 isParatext "false" @default.
- W2030430070 isRetracted "false" @default.
- W2030430070 magId "2030430070" @default.
- W2030430070 workType "article" @default.
!["International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004;363:9–17. [OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] Q In patients with acute, uncomplicated Plasmodium falciparum malaria, does the addition of an artemisinin derivative (artesunate) to existing drug treatment reduce treatment failure and transmission potential? Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Infectious disease ★★★★★☆☆ Tropical medicine ★★★★★★☆ ### ![Graphic][5]</img>Data sources: Medline, Cochrane Central Register of Controlled Trials, and investigators in the field. Individual patient data were requested from the original trial datasets. ### ![Graphic][6]</img>Study selection and assessment: randomised controlled trials (RCTs) comparing artesunate plus a standard antimalarial drug with a standard drug alone for acute, uncomplicated P falciparum malaria. Study quality was assessed by adequacy of random allocation, inclusion of … [1]: {openurl}?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DAdjuik%26rft.auinit1%253DM.%26rft.volume%253D363%26rft.issue%253D9402%26rft.spage%253D9%26rft.epage%253D17%26rft.atitle%253DArtesunate%2Bcombinations%2Bfor%2Btreatment%2Bof%2Bmalaria%253A%2Bmeta-analysis.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252803%252915162-8%26rft_id%253Dinfo%253Apmid%252F14723987%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.1016/S0140-6736(03)15162-8&link_type=DOI [3]: /lookup/external-ref?access_num=14723987&link_type=MED&atom=%2Febmed%2F9%2F5%2F150.atom [4]: /lookup/external-ref?access_num=000187711300008&link_type=ISI [5]: /embed/inline-graphic-1.gif [6]: /embed/inline-graphic-2.gif"](?object=%22International%20Artemisinin%20Study%20Group.%20Artesunate%20combinations%20for%20treatment%20of%20malaria%3A%20meta-analysis.%20Lancet%202004%3B363%3A9%E2%80%9317.%20%5BOpenUrl%5D%5B1%5D%5BCrossRef%5D%5B2%5D%5BPubMed%5D%5B3%5D%5BWeb%20of%20Science%5D%5B4%5D%20Q%20In%20patients%20with%20acute%2C%20uncomplicated%20Plasmodium%20falciparum%20malaria%2C%20does%20the%20addition%20of%20an%20artemisinin%20derivative%20(artesunate)%20to%20existing%20drug%20treatment%20reduce%20treatment%20failure%20and%20transmission%20potential%3F%20Clinical%20impact%20ratings%20GP%2FFP%2FPrimary%20care%20%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%86%20Infectious%20disease%20%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%86%E2%98%86%20Tropical%20medicine%20%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%86%20%23%23%23%20!%5BGraphic%5D%5B5%5D%3C%2Fimg%3EData%20sources%3A%20Medline%2C%20Cochrane%20Central%20Register%20of%20Controlled%20Trials%2C%20and%20investigators%20in%20the%20field.%20Individual%20patient%20data%20were%20requested%20from%20the%20original%20trial%20datasets.%20%23%23%23%20!%5BGraphic%5D%5B6%5D%3C%2Fimg%3EStudy%20selection%20and%20assessment%3A%20randomised%20controlled%20trials%20(RCTs)%20comparing%20artesunate%20plus%20a%20standard%20antimalarial%20drug%20with%20a%20standard%20drug%20alone%20for%20acute%2C%20uncomplicated%20P%20falciparum%20malaria.%20Study%20quality%20was%20assessed%20by%20adequacy%20of%20random%20allocation%2C%20inclusion%20of%20%E2%80%A6%20%5B1%5D%3A%20%7Bopenurl%7D%3Fquery%3Drft.jtitle%25253DLancet%2526rft.stitle%25253DLancet%2526rft.aulast%25253DAdjuik%2526rft.auinit1%25253DM.%2526rft.volume%25253D363%2526rft.issue%25253D9402%2526rft.spage%25253D9%2526rft.epage%25253D17%2526rft.atitle%25253DArtesunate%252Bcombinations%252Bfor%252Btreatment%252Bof%252Bmalaria%25253A%252Bmeta-analysis.%2526rft_id%25253Dinfo%25253Adoi%25252F10.1016%25252FS0140-6736%25252803%25252915162-8%2526rft_id%25253Dinfo%25253Apmid%25252F14723987%2526rft.genre%25253Darticle%2526rft_val_fmt%25253Dinfo%25253Aofi%25252Ffmt%25253Akev%25253Amtx%25253Ajournal%2526ctx_ver%25253DZ39.88-2004%2526url_ver%25253DZ39.88-2004%2526url_ctx_fmt%25253Dinfo%25253Aofi%25252Ffmt%25253Akev%25253Amtx%25253Actx%20%5B2%5D%3A%20%2Flookup%2Fexternal-ref%3Faccess_num%3D10.1016%2FS0140-6736(03)15162-8%26link_type%3DDOI%20%5B3%5D%3A%20%2Flookup%2Fexternal-ref%3Faccess_num%3D14723987%26link_type%3DMED%26atom%3D%252Febmed%252F9%252F5%252F150.atom%20%5B4%5D%3A%20%2Flookup%2Fexternal-ref%3Faccess_num%3D000187711300008%26link_type%3DISI%20%5B5%5D%3A%20%2Fembed%2Finline-graphic-1.gif%20%5B6%5D%3A%20%2Fembed%2Finline-graphic-2.gif%22){kind=link}